17
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial.

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Prostate cancer might have high radiation-fraction sensitivity, implying a therapeutic advantage of hypofractionated treatment. We present a pre-planned preliminary safety analysis of side-effects in stages 1 and 2 of a randomised trial comparing standard and hypofractionated radiotherapy.

          Related collections

          Author and article information

          Journal
          Lancet Oncol
          The Lancet. Oncology
          Elsevier BV
          1474-5488
          1470-2045
          Jan 2012
          : 13
          : 1
          Affiliations
          [1 ] Royal Marsden NHS Foundation Trust, London, UK. david.dearnaley@icr.ac.uk
          Article
          S1470-2045(11)70293-5
          10.1016/S1470-2045(11)70293-5
          22169269
          349ad3a2-d425-4a9f-beb2-657d6f94e841
          Copyright © 2012 Elsevier Ltd. All rights reserved.
          History

          Comments

          Comment on this article